F. Perry Wilson

F. Perry Wilson, MD is an Associate Professor of Medicine and Public Health at the Yale University School of Medicine. He specializes in clinical epidemiology and leverages patient-level data and advanced analytics to advance personalized medicine. Dr. Wilson holds multiple NIH grants and directs Yale’s Clinical and Translational Research Accelerator, focusing on accelerating research translation. He is known for his expertise in medical study design and interpretation, appearing in prominent media outlets like Medscape and the Huffington Post.

Education:

• Bachelor’s in Biochemistry, Harvard College (cum laude)
• MD from Columbia University College of Physicians and Surgeons
• Master’s in Clinical Epidemiology (MSCE), University of Pennsylvania

Research Focus: Dr. Wilson’s work bridges clinical practice and population health, emphasizing evidence-based medicine and critical analysis of medical research. His interdisciplinary approach integrates epidemiology, biostatistics, and public health to address gaps in personalized care and healthcare innovation.

Recent Article Trends: His analyses highlight emerging topics like neuropharmacology of psychedelics, off-target drug effects of weight-loss medications, and wearable technology’s role in cardiovascular diagnostics. These studies underscore his commitment to actionable insights from complex biomedical data.

Grants and Leadership: NIH-funded projects include studies on aging biomarkers and neurodegenerative mechanisms. As host of Medscape’s Impact Factor, he demystifies medical research for broader audiences.

Labs/Teams: Leads the Yale Clinical and Translational Research Accelerator, fostering collaboration between clinicians and data scientists to streamline translational research.